Mélissa Bowerman

1.9k total citations
38 papers, 1.3k citations indexed

About

Mélissa Bowerman is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Mélissa Bowerman has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 32 papers in Genetics and 7 papers in Neurology. Recurrent topics in Mélissa Bowerman's work include Neurogenetic and Muscular Disorders Research (32 papers), RNA modifications and cancer (24 papers) and RNA Research and Splicing (10 papers). Mélissa Bowerman is often cited by papers focused on Neurogenetic and Muscular Disorders Research (32 papers), RNA modifications and cancer (24 papers) and RNA Research and Splicing (10 papers). Mélissa Bowerman collaborates with scholars based in United Kingdom, Canada and France. Mélissa Bowerman's co-authors include Rashmi Kothary, Ariane Beauvais, Carrie L. Anderson, Lyndsay M. Murray, Matthew J. A. Wood, Kevin Talbot, Justin G. Boyer, Cédric Raoul, Bruno Botelho Pinheiro and John‐Paul Michalski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Neurology and Neuroscience.

In The Last Decade

Mélissa Bowerman

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélissa Bowerman United Kingdom 17 1.1k 1.0k 286 144 97 38 1.3k
Lyndsay M. Murray United Kingdom 22 1.5k 1.4× 1.5k 1.5× 383 1.3× 271 1.9× 181 1.9× 40 1.9k
Kentaro Sahashi Japan 15 1.5k 1.4× 1.0k 1.0× 299 1.0× 129 0.9× 280 2.9× 36 1.8k
Markus Rießland Germany 19 1.3k 1.2× 1.1k 1.1× 371 1.3× 122 0.8× 135 1.4× 32 1.6k
Tristan H. Coady United States 12 590 0.6× 396 0.4× 94 0.3× 142 1.0× 59 0.6× 12 726
Charlotte J. Sumner United States 12 796 0.8× 654 0.7× 150 0.5× 152 1.1× 313 3.2× 22 1.2k
Tara Martinez United States 9 581 0.6× 422 0.4× 143 0.5× 114 0.8× 209 2.2× 9 899
Shingo Kariya United States 16 1.1k 1.1× 916 0.9× 265 0.9× 267 1.9× 243 2.5× 29 1.6k
Ferrill F. Rose United States 9 1.2k 1.1× 398 0.4× 204 0.7× 101 0.7× 220 2.3× 12 1.4k
Irene Faravelli Italy 19 682 0.6× 354 0.4× 110 0.4× 223 1.5× 210 2.2× 41 1.0k
Matthew Wyles United Kingdom 11 474 0.5× 397 0.4× 98 0.3× 224 1.6× 65 0.7× 13 706

Countries citing papers authored by Mélissa Bowerman

Since Specialization
Citations

This map shows the geographic impact of Mélissa Bowerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélissa Bowerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélissa Bowerman more than expected).

Fields of papers citing papers by Mélissa Bowerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélissa Bowerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélissa Bowerman. The network helps show where Mélissa Bowerman may publish in the future.

Co-authorship network of co-authors of Mélissa Bowerman

This figure shows the co-authorship network connecting the top 25 collaborators of Mélissa Bowerman. A scholar is included among the top collaborators of Mélissa Bowerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélissa Bowerman. Mélissa Bowerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Brown, Sharon J., et al.. (2023). Enhanced expression of the human Survival motor neuron 1 gene from a codon-optimised cDNA transgene in vitro and in vivo. Gene Therapy. 30(12). 812–825. 1 indexed citations
3.
Bernard‐Marissal, Nathalie, Cécile Hilaire, Frédérique Scamps, et al.. (2023). Differential effect of Fas activation on spinal muscular atrophy motoneuron death and induction of axonal growth. Cellular and Molecular Biology. 69(10). 1–8. 2 indexed citations
4.
Brown, Sharon J., Silvia A. Synowsky, Sally L. Shirran, et al.. (2023). AAV9-mediated SMN gene therapy rescues cardiac desmin but not lamin A/C and elastin dysregulation in Smn 2B/− spinal muscular atrophy mice. Human Molecular Genetics. 32(20). 2950–2965. 3 indexed citations
6.
Meijboom, Katharina E., Daniel C. Anthony, Benjamin Edwards, et al.. (2022). Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice. Skeletal Muscle. 12(1). 18–18. 6 indexed citations
7.
Meijboom, Katharina E., Viola Volpato, Jimena Monzón‐Sandoval, et al.. (2021). Combining multiomics and drug perturbation profiles to identify muscle-specific treatments for spinal muscular atrophy. JCI Insight. 6(13). 13 indexed citations
8.
Grunseich, Christopher, George G. Harmison, Carlo Rinaldi, et al.. (2021). Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy. Molecular Therapy — Nucleic Acids. 23. 731–742. 14 indexed citations
9.
Bowerman, Mélissa, Lyndsay M. Murray, Frédérique Scamps, et al.. (2017). Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: Converging roads to therapeutic development. European Journal of Medical Genetics. 61(11). 685–698. 21 indexed citations
10.
Bowerman, Mélissa, Catherina G. Becker, Rafael J. Yáñez‐Muñoz, et al.. (2017). Therapeutic strategies for spinal muscular atrophy: SMN and beyond. Disease Models & Mechanisms. 10(8). 943–954. 78 indexed citations
11.
Bowerman, Mélissa, Véronique Bernard, Annie Dionne, et al.. (2017). KCC3 loss-of-function contributes to Andermann syndrome by inducing activity-dependent neuromuscular junction defects. Neurobiology of Disease. 106. 35–48. 6 indexed citations
12.
Rousset, Matthieu, Thierry Cens, Claudine Ménard, et al.. (2015). Regulation of neuronal high-voltage activated CaV2 Ca2+ channels by the small GTPase RhoA. Neuropharmacology. 97. 201–209. 6 indexed citations
13.
Bowerman, Mélissa, et al.. (2015). Tweak regulates astrogliosis, microgliosis and skeletal muscle atrophy in a mouse model of amyotrophic lateral sclerosis. Human Molecular Genetics. 24(12). 3440–3456. 27 indexed citations
14.
Scamps, Frédérique, Sina Sangari, Mélissa Bowerman, et al.. (2014). Nerve injury induces a Gem-GTPase-dependent downregulation of P/Q-type Ca2+ channels contributing to neurite plasticity in dorsal root ganglion neurons. Pflügers Archiv - European Journal of Physiology. 467(2). 351–366. 7 indexed citations
15.
Raoul, Cédric, et al.. (2014). ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets. Frontiers in Neuroscience. 8. 271–271. 31 indexed citations
16.
Bowerman, Mélissa, et al.. (2013). Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis. Frontiers in Cellular Neuroscience. 7. 214–214. 36 indexed citations
17.
Bowerman, Mélissa, Kathryn J. Swoboda, John‐Paul Michalski, et al.. (2012). Glucose metabolism and pancreatic defects in spinal muscular atrophy. Annals of Neurology. 72(2). 256–268. 122 indexed citations
18.
Bowerman, Mélissa, Lyndsay M. Murray, Justin G. Boyer, Carrie L. Anderson, & Rashmi Kothary. (2012). Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy. BMC Medicine. 10(1). 24–24. 98 indexed citations
19.
Bowerman, Mélissa, Ariane Beauvais, Carrie L. Anderson, & Rashmi Kothary. (2010). Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Human Molecular Genetics. 19(8). 1468–1478. 136 indexed citations
20.
Mattis, Virginia B., Mélissa Bowerman, Rashmi Kothary, & Christian L. Lorson. (2008). A SMNΔ7 read-through product confers functionality to the SMNΔ7 protein. Neuroscience Letters. 442(1). 54–58. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026